AKDITAL Investor Presentation
CONSOLIDATED FINANCIAL STATEMENTS - INCOME STATEMENT (1/2)
2022 KEY FIGURES
Figures in M MAD
Revenue
1.035
34,4%
770
EBITDA
EBITDA margin
283
51,8% →
186
Net income
Net margin
99
77,1%
56
27%
10%
24%
7%
2021
Proforma
2022
Revenue: outstanding performance vs. 2021
2021
Proforma
Full-year effect of the openings and acquisitions in 2021 (HPE, CIOJ, Vinci and Atfal).
Growth of historical clinics (CIOC, CJO, HPC, CCAB, CMCL).
Contribution from 2022 openings (HPT, CIOBT, CSS, CIOA, HIA, HPS, CIOS, CPSM).
EBITDA: strong growth vs. 2021
Strong revenue growth
Improvement of the gross margin of the different entities
Procurement optimization, including in particular the cost of consumables and
medical devices as part of the Group's policy of centralizing purchases.
2022
2021
Proforma
Net income: outperformance of net income
2022
Growth in revenue and EBITDA combined with an improvement in one off results.
Investor Presentation - June 2023
18View entire presentation